Biosafety of Genetically Modified Organisms in the Latin American and the Caribbean Region: Main Needs and Opportunities for Strategic Capacity Building

MOspace/Manakin Repository

Breadcrumbs Navigation

Biosafety of Genetically Modified Organisms in the Latin American and the Caribbean Region: Main Needs and Opportunities for Strategic Capacity Building

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/14925

[+] show full item record


Title: Biosafety of Genetically Modified Organisms in the Latin American and the Caribbean Region: Main Needs and Opportunities for Strategic Capacity Building
Author: Araya-Quesada, Marianela; Craig, Wendy; Ripandelli, Decio
Keywords: biosafety
genetically modified organisms
capacity building
Latin America
Caribbean
agricultural development
poverty reduction
Date: 2012
Publisher: AgBioForum
Citation: AgBioForum, 15(1), 77-88.
Abstract: Biotechnology has the potential to help improve food production in Latin America and the Caribbean (LAC), a continent where agriculture plays a dominant role in peoples' lives and in trade. It is therefore critical that recombinant DNA (rDNA) biotechnology is regulated in such a manner as to capture its benefits and to minimize any potential risks. In order to best understand biosafety needs in LAC, an email-based stakeholder consultation was carried out, augmented by personal communications with well-informed respondents, and integrated into a desktop study incorporating information from recent peer-reviewed literature. The resultant qualitative study tracked developments in rDNA biotechnology and biosafety in the region and reviewed regulatory capacity as well as the legacies of previous capacity-building projects in these areas to culminate in a snapshot of the present situation. It demonstrated that approximately half of the 31 countries represented in the study are not carrying out any domestic research and development on genetically modified organisms (GMOs); furthermore, the majority have not developed GM products beyond the proof-of-concept stage. Only 58% of the study countries appear to have operational biosafety regulatory systems in place. Acknowledging that methods of delivering capacity building should be tailored to specific demand-driven needs, the study identified possible knowledge and expertise gaps in the region, to be used as a basis for possible training and/or support interventions.
URI: http://hdl.handle.net/10355/14925
ISSN: 1522-936X

This item appears in the following Collection(s)

[+] show full item record